跳至主要内容
临床试验/NCT01408979
NCT01408979已完成4 期

Postpartum Prophylaxis With Short Course Magnesium Sulfate in Severe Preeclampsia: a Randomized Clinical Trial

Instituto Materno Infantil Prof. Fernando Figueira1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2011年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
120
试验地点
1
主要终点
Need to continue therapy for another 12 hours.

研究概览

简要总结

Magnesium sulfate is the ideal drug for seizures prophilaxis in preeclampsia. The ideal duration of this treatment after delivery is still to be established. The hypothesis is that in stable patients a shorter course of treatment is possible without prejudice to the mother.

详细描述

Magnesium sulfate (MgSO4) is certainly the ideal drug for prevention and control of eclamptic seizures. However, there is no consensus on the appropriate duration of prophylaxis with this anticonvulsant postpartum.The objective of the present study is to compare effectiveness of 12 hours of magnesium sulfate versus 24 hours (standard treatment) in stable patients with preeclampsia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
11 Years 至 50 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Pre-eclampsia;
  • Puerperium.

排除标准

  • Associated maternal diseases;
  • Use of illicit drugs or other medications that might interfere with maternal hemodynamics;
  • Contraindications to the use of magnesium sulfate: drug hypersensitivity, oliguria with urine output below 25ml/h; anuria (absent urine output), myasthenia gravis.

研究组 & 干预措施

12 hours of magnesium sulfate

Experimental

Patients in this group will have magnesium sulfate administered for 12 hours after delivery

干预措施: Magnesium sulfate 12 hours (Drug)

24 hours of magnesium sulfate

Active Comparator

Patients in this group will have magnesium sulfate administered for 24 hours after delivery

干预措施: Magnesium sulfate 24 hours (Drug)

结局指标

主要结局

Need to continue therapy for another 12 hours.

时间窗: 24 hours

Defined as the need to continue therapy for another 12 hours, this will occur when after the first 12 hours of magnesium sulfate therapy the patient has severe hypertension, unsatisfactory diureses or has signs or symptoms of iminent eclampsia.

次要结局

  • Satisfaction(24 hours)

研究者

发起方
Instituto Materno Infantil Prof. Fernando Figueira
申办方类型
Other
责任方
Principal Investigator
主要研究者

Leila Katz

Obstetrical ICU obstetrical coordinator; MD , PhD

Instituto Materno Infantil Prof. Fernando Figueira

研究点 (1)

Loading locations...

相似试验